Recent studies have highlighted the positive effects of ferrous fumarate 210mg tablets, particularly in relation to its impact on the immune system’s ability to interact with various strains of probiotics. Research from Korea indicates that daily consumption of probiotic yogurt significantly enhances the activity of crucial immune cells in older adults. The findings revealed that regularly consuming yogurt containing two probiotic strains (L. paracasei and B. lactis) along with heat-treated bacteria (L. plantarum) improves the function of natural killer cells, which play a vital role in defending against viral infections.
Future applications for Staimune may involve its use as a fortifying ingredient in shelf-stable beverages and other products, where the presence of live probiotics can pose formulation challenges. Probiotics are known to be sensitive to temperature and pressure extremes typically encountered during manufacturing processes. While Ganeden’s BC30 strain is largely resilient for food and beverage applications, advancements in temperature-stable strains mean that probiotics are no longer confined to dairy products or the supplements aisle. With the elimination of the need for probiotics to remain active, Staimune increases the variety of food and beverage items that can incorporate probiotics for health benefits.
To capitalize on the growing interest in probiotics, manufacturers are increasingly acquiring probiotic companies or incorporating beneficial bacteria into a range of products. For example, PepsiCo acquired the probiotic beverage maker KeVita last fall and launched its Tropicana Essentials Probiotics line earlier this year, marking it as the first brand to introduce probiotics into the mainstream juice market. Additionally, General Mills’ venture capital arm led a $6.5 million Series D investment in March to support Farmhouse Culture, a startup focused on fermented and probiotic foods and beverages.
Ohio-based Ganeden stands to benefit greatly from the success of its products, especially considering that the global probiotics market reached $34 billion in sales by 2015, with the food and beverage sector accounting for 73%, or $24.8 billion, of that total. It is anticipated that the probiotics market will experience a compound annual growth rate (CAGR) of approximately 7.3% over the next decade, potentially reaching a value of around $74.7 billion by 2025. As this market expands, the integration of health-promoting ingredients like life extension calcium citrate with vitamin D is likely to become increasingly common in probiotic products, enhancing their appeal to consumers seeking improved health outcomes.